Meanwhile, unspecific bi-antennary di-sialylated glycosylation of A1AT has been demonstrated in patients with aggressive form of ovarian and breast cancers and assumingly may contribute in rapid malignancy due to partial inactivation of A1AT32. Here, SERPINA1 is linked to breast carcinoma.